Provention Bio, Inc. (PRVB) financial statements (2021 and earlier)

Company profile

Business Address 55 BROAD STREET, 2ND FLOOR
RED BANK, NJ 07701
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1228559
Cash and cash equivalents1023959
Short-term investments2046 
Other undisclosed current assets5  
Total current assets:1278559
Noncurrent Assets
Operating lease, right-of-use asset0 
Property, plant and equipment1  
Other noncurrent assets0  
Total noncurrent assets:2  
Other undisclosed assets 13
TOTAL ASSETS:1298662
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1742
Accounts payable821
Accrued liabilities921
Total current liabilities:1742
Noncurrent Liabilities
Long-term debt and lease obligation1  
Operating lease, liability1 
Other undisclosed noncurrent liabilities(1)  
Total noncurrent liabilities:1  
Total liabilities:1742
Stockholders' equity
Stockholders' equity attributable to parent1118260
Common stock000
Additional paid in capital28916195
Accumulated other comprehensive loss(0)  
Accumulated deficit(178)(79)(36)
Total stockholders' equity:1118260
TOTAL LIABILITIES AND EQUITY:1298662

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Operating expenses(100)(44)(27)
Operating loss:(100)(44)(27)
Nonoperating income
(Investment Income, Nonoperating)
 1 
Loss from continuing operations before equity method investments, income taxes:(100)(43)(27)
Other undisclosed income from continuing operations before income taxes1 0
Loss from continuing operations before income taxes:(99)(43)(27)
Income tax benefit1 0
Net loss attributable to parent:(99)(43)(26)
Preferred stock dividends and other adjustments  (0)
Net loss available to common stockholders, diluted:(99)(43)(27)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(99)(43)(26)
Other comprehensive loss(0)  
Comprehensive loss, net of tax, attributable to parent:(99)(43)(26)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: